Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 26 Artikel )

13.10.2018 | Review | Ausgabe 2/2019

One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis

Alessandro Inno, Sandro Barni, Antonio Ghidini, Alberto Zaniboni, Fausto Petrelli

15.10.2018 | Review | Ausgabe 2/2019

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients

Hye Won Hwang, Hera Jung, Jiyeon Hyeon, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jong-Han Yu, Se Kyung Lee, Misun Choi, Soo Youn Cho, Eun Yoon Cho

25.10.2018 | Review | Ausgabe 2/2019

Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis

Michael M. Jonczyk, Jolie Jean, Roger Graham, Abhishek Chatterjee

10.10.2018 | Preclinical study | Ausgabe 2/2019

Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Fouzia Guestini, Katsuhiko Ono, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, Saki Nakagawa, Hisashi Hirakawa, Kentaro Tamaki, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara, Hironobu Sasano, Keely May McNamara

13.10.2018 | Preclinical study | Ausgabe 2/2019

Mucin 2 (MUC2) modulates the aggressiveness of breast cancer

Anna Astashchanka, Thomas M. Shroka, Britta M. Jacobsen

20.10.2018 | Preclinical study | Ausgabe 2/2019

Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database

Anna M. Mazor, Alina M. Mateo, Lyudmila Demora, Elin R. Sigurdson, Elizabeth Handorf, John M. Daly, Allison A. Aggon, Penny R. Anderson, Stephanie E. Weiss, Richard J. Bleicher

11.10.2018 | Clinical trial | Ausgabe 2/2019 Open Access

High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study

Martin P. Nilsson, Erik D. Nilsson, Åke Borg, Yvonne Brandberg, Barbro Silfverberg, Niklas Loman

15.10.2018 | Clinical trial | Ausgabe 2/2019

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Peter A. Fasching, Andreas D. Hartkopf, Paul Gass, Lothar Häberle, Leyla Akpolat-Basci, Alexander Hein, Bernhard Volz, Florin-Andrei Taran, Naiba Nabieva, Birgit Pott, Friedrich Overkamp, Hanna Einarson, Peyman Hadji, Hans Tesch, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Wolfgang Janni, Tanja N. Fehm, Andreas Schneeweiss, Michael Untch, Dirk Pott, Michael P. Lux, Thomas Geyer, Cornelia Liedtke, Harald Seeger, Sarah Wetzig, Arndt Hartmann, Rüdiger Schulz-Wendtland, Erik Belleville, Diethelm Wallwiener, Matthias W. Beckmann, Sara Y. Brucker, Hans-Christian Kolberg

19.10.2018 | Clinical trial | Ausgabe 2/2019

Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis

Xuexin He, Jiali Ji, Rongrong Dong, Hong Liu, Xiaolan Dai, Chongjian Wang, Francisco J. Esteva, Sai-Ching Jim Yeung

20.10.2018 | Clinical trial | Ausgabe 2/2019

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean-Marc Classe, Cecile Loaec, P. Gimbergues, S. Alran, C. Tunon de Lara, P. F. Dupre, Roman Rouzier, C. Faure, N. Paillocher, M. P. Chauvet, G. Houvenaeghel, M. Gutowski, P. De Blay, J. L. Verhaeghe, E. Barranger, C. Lefebvre, C. Ngo, G. Ferron, C. Palpacuer, L. Campion

20.10.2018 | Clinical trial | Ausgabe 2/2019

A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer

Carlos Blanco, John C. Markowitz, David J. Hellerstein, Arthur M. Nezu, Melanie Wall, Mark Olfson, Ying Chen, Jon Levenson, Maika Onishi, Cindy Varona, Mayumi Okuda, Dawn L. Hershman

20.10.2018 | Clinical trial | Ausgabe 2/2019

Machine learning for diagnostic ultrasound of triple-negative breast cancer

Tong Wu, Laith R. Sultan, Jiawei Tian, Theodore W. Cary, Chandra M. Sehgal

22.10.2018 | Clinical trial | Ausgabe 2/2019

Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score

Piiha-Lotta Jerevall, Jane Brock, Juan Palazzo, Tad Wieczorek, Michael Misialek, Anthony J. Guidi, Yun Wu, Mark G. Erlander, Yi Zhang, Catherine A. Schnabel, Paul E. Goss, Nora Horick, Dennis C. Sgroi

22.10.2018 | Clinical trial | Ausgabe 2/2019

Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Jai Min Ryu, Hee Jun Choi, Isaac Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Se Kyung Lee, Doo Ho Choi, Yeon Hee Park, Jong-Won Kim, Jeong-sun Seo, Jung-Hoon Park, Jeong Eon Lee, Sung-Won Kim, Korean Hereditary Breast Cancer Study Group

24.10.2018 | Clinical trial | Ausgabe 2/2019

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

Luc Cabel, Matthieu Carton, Bianca Cheaib, Jean-Yves Pierga, Florence Dalenc, Audrey Mailliez, Christelle Levy, William Jacot, Marc Debled, Marianne Leheurteur, Isabelle Desmoulins, Claudia Lefeuvre, Anthony Gonçalves, Lionel Uwer, Jean-Marc Ferrero, Jean-Christophe Eymard, Thierry Petit, Marie-Ange Mouret-Reynier, Geneviève Perrocheau, Irwin Piot, David Pérol, Gaëtane Simon, Florence Lerebours

25.10.2018 | Clinical trial | Ausgabe 2/2019

Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial

Jian-wei Li, Wen-jia Zuo, Diana Ivanova, Xiao-qing Jia, Li Lei, Guang-yu Liu

10.10.2018 | Epidemiology | Ausgabe 2/2019

The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations

Laura Panattoni, Tracy A. Lieu, Jinani Jayasekera, Suzanne O’Neill, Jeanne S. Mandelblatt, Ruth Etzioni, Charles E. Phelps, Scott D. Ramsey

12.10.2018 | Epidemiology | Ausgabe 2/2019

Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

André Hennigs, Melitta Köpke, Manuel Feißt, Fabian Riedel, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Andreas Schneeweiss, Jörg Heil

12.10.2018 | Epidemiology | Ausgabe 2/2019

Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum

Fernando A. Angarita, Benjamin Price, Matthew Castelo, Mauricio Tawil, Juan Carlos Ayala, Lilian Torregrossa

16.10.2018 | Epidemiology | Ausgabe 2/2019

The influence of reconstruction choice and inclusion of radiation therapy on functional shoulder biomechanics in women undergoing mastectomy for breast cancer

Joshua M. Leonardis, Brian J. Diefenbach, Daniel A. Lyons, Thomas A. Olinger, Aviram M. Giladi, Adeyiza O. Momoh, David B. Lipps

16.10.2018 | Epidemiology | Ausgabe 2/2019

Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set

Elizabeth Hope Cain, Ashirbani Saha, Michael R. Harowicz, Jeffrey R. Marks, P. Kelly Marcom, Maciej A. Mazurowski

16.10.2018 | Epidemiology | Ausgabe 2/2019

Predictors of time to death after distant recurrence in breast cancer patients

Victoria Sopik, Ping Sun, Steven A. Narod

23.10.2018 | Epidemiology | Ausgabe 2/2019 Open Access

Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy

Maaike M. G. A. van den Berg, Dieuwertje E. Kok, Liesbeth Posthuma, Lisette Kamps, Celine S. Kelfkens, Nicole Buist, Maud Geenen, Annebeth Haringhuizen, Joan B. Heijns, Rianne H. M. A. van Lieshout, Maartje Los, Dirkje W. Sommeijer, Johanna N. H. Timmer-Bonte, Anja Th. C. M. de Kruif, Hanneke W. M. van Laarhoven, Ellen Kampman, Renate M. Winkels

15.10.2018 | Letter to the Editor | Ausgabe 2/2019

Better pathological tumor characteristics might occur in recurrent metastatic breast cancer patients after 10-year metastatic free interval

Kadri Altundag

20.10.2018 | Letter to the Editor | Ausgabe 2/2019

Extranodular extension in sentinel lymph node-positive breast cancer might predict further initiation of completion axillary lymph node dissection

Kadri Altundag

23.11.2018 | Correction | Ausgabe 2/2019

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis

Jiayu Wang, Binghe Xu, Wenna Wang, Xiaoyu Zhai, Xuelian Chen

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise